Teva Pharmaceuticals USA is recalling 108,122 bottles of Metformin Hydrochloride Extended-Release (ER) Tablets, a medication used to treat type 2 diabetes. The recall includes both 500 mg and 750 mg strengths distributed under the Actavis Pharma brand. Testing by the FDA found levels of N-Nitrosodimethylamine (NDMA) that exceed the acceptable daily intake limit, which is a substance that could potentially increase the risk of cancer. These prescription medications were distributed nationwide across the United States and Puerto Rico.
Laboratory analysis detected N-Nitrosodimethylamine (NDMA) at levels higher than what the FDA considers safe for daily consumption. NDMA is classified as a probable human carcinogen, meaning long-term exposure to levels above the acceptable limit may increase the risk of developing cancer.
Healthcare provider consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.